Most customers, rivals offer no objection to Merck-Sigma merger deal
Most customers and rivals consulted by the Brazilian antitrust authority offered no objections to the planned $17 billion acquisition by German pharmaceutical company Merck KGaA of rival Sigma-Aldrich. About 100 companies...To view the full article, register now.
Already a subscriber? Click here to view full article